JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$2.2B |
| 3 |
Microsoft
MSFT
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.94B |
| 5 |
Goldman Sachs
GS
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.77B |
| 2 |
Broadcom
AVGO
|
+$1.88B |
| 3 |
TSMC
TSM
|
+$1.18B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.14B |
| 5 |
Danaher
DHR
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 9.21% |
| 4 | Financials | 9.1% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
CALL
Global Payments
GPN
$24.6B
| $2.5M | ﹤0.01% |
24,400
+23,600
| +2,950% | +$2.45M |
|
3677
SI-BONE Inc
SIBN
$848M
| $2.49M | ﹤0.01% |
177,793
+22,732
| +15% | +$342K |
|
3678
National Beverage
FIZZ
$2.93B
| $2.48M | ﹤0.01% |
52,924
-12,984
| -20% | -$616K |
|
|
QHY
3679
WisdomTree U.S. High Yield Corporate Bond Fund
QHY
$243M
| $2.48M | ﹤0.01% |
53,650
-3,396
| -6% | -$155K |
|
3680
CryoPort
CYRX
$772M
| $2.48M | ﹤0.01% |
305,237
+285,726
| +1,464% | +$2.34M |
|
3681
CALL
Thermo Fisher Scientific
TMO
$218B
| $2.47M | ﹤0.01% |
4,000
+1,600
| +67% | +$947K |
|
3682
CALL
McKesson
MCK
$101B
| $2.47M | ﹤0.01% |
5,000
| – | – |
|
3683
CALL
Southern Company
SO
$107B
| $2.47M | ﹤0.01% |
27,400
+17,800
| +185% | +$1.52M |
|
3684
CALL
Service Corp International
SCI
$11.5B
| $2.47M | ﹤0.01% |
+31,300
| New | +$2.38M |
|
3685
Capital Group US Multi-Sector Income ETF
CGMS
$5.42B
| $2.47M | ﹤0.01% |
88,695
-3,595
| -4% | -$98.9K |
|
3686
Midland States Bancorp
MSBI
$693M
| $2.47M | ﹤0.01% |
110,306
+37,889
| +52% | +$860K |
|
3687
Schwab Fundamental US Small Company Index ETF
FNDA
$9.45B
| $2.47M | ﹤0.01% |
82,860
-2,226
| -3% | -$64K |
|
3688
Hippo Holdings
HIPO
$872M
| $2.47M | ﹤0.01% |
146,176
+98,256
| +205% | +$1.77M |
|
3689
Franklin US Low Volatility High Dividend Index ETF
LVHD
$632M
| $2.47M | ﹤0.01% |
60,573
+4,780
| +9% | +$185K |
|
3690
PUT
NovoCure
NVCR
$1.97B
| $2.47M | ﹤0.01% |
+157,800
| New | +$2.86M |
|
3691
PUT
Coupang
CPNG
$29B
| $2.46M | ﹤0.01% |
+100,000
| New | +$2.22M |
|
3692
Hartford Large Cap Growth ETF
HFGO
$210M
| $2.46M | ﹤0.01% |
113,515
-482,460
| -81% | -$10M |
|
3693
CALL
Pultegroup
PHM
$24.8B
| $2.45M | ﹤0.01% |
17,100
| – | – |
|
3694
ATS Corp
ATS
$1.99B
| $2.45M | ﹤0.01% |
84,474
-156,112
| -65% | -$4.51M |
|
3695
Interface
TILE
$2.19B
| $2.45M | ﹤0.01% |
129,264
+23,447
| +22% | +$404K |
|
3696
Forestar Group
FOR
$1.5B
| $2.45M | ﹤0.01% |
75,713
-261,437
| -78% | -$8.14M |
|
3697
Phathom Pharmaceuticals
PHAT
$775M
| $2.45M | ﹤0.01% |
135,431
+1,074
| +0.8% | +$15K |
|
3698
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.26B
| $2.45M | ﹤0.01% |
26,267
+328
| +1% | +$29.6K |
|
|
HAYN
3699
DELISTED
Haynes International, Inc.
HAYN
| $2.45M | ﹤0.01% |
41,072
-518
| -1% | -$30.8K |
|
3700
Taboola.com
TBLA
$1.09B
| $2.44M | ﹤0.01% |
727,181
+257,009
| +55% | +$847K |
|
Similar funds
JP Morgan Chase's Q3 2024 Portfolio in Review
As of Q3 2024, JP Morgan Chase held 7,854 positions worth $1.32T, up 7.9% from $1.22T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase's Q3 2024 filing shows 533 new, 3,476 increased, 2,341 reduced and 444 closed positions. Its largest new stake was Smurfit Westrock: 4,472,396 shares worth $221M. The largest sale was Advanced Micro Devices, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q3 2024 buy was Smurfit Westrock: 4,472,396 shares worth $221M.
- JP Morgan Chase added most to iShares Broad USD High Yield Corporate Bond ETF in Q3 2024, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $2.77B.
- JP Morgan Chase fully exited WestRock Company in Q3 2024, selling an estimated $320M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.32T portfolio in Q3 2024.
- JP Morgan Chase opened 533 new positions and closed 444 in Q3 2024.
- JP Morgan Chase's portfolio value rose 7.9% quarter-over-quarter to $1.32T.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.